Dynamic molecular monitoring reveals that SWI–SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphomaRishu Agarwal, Sarah‐Jane Dawson, Rachel Thijssen et al.|Nature Medicine|2018Cited by 204
Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemiaCharles C. Bell, Mark A. Dawson|Nature Communications|2019Cited by 178
CDK4/6 inhibition reprograms the breast cancer enhancer landscape by stimulating AP-1 transcriptional activityApril C. Watt, Shom Goel, Paloma Cejas et al.|Nature Cancer|2020Cited by 110